Guardian Capital Advisors LP Increased Its Suncor Energy New (SU) Holding; 3 Analysts Covering Kamada Ltd. (KMDA)

April 21, 2018 - By Linda Rogers

Suncor Energy Inc. (NYSE:SU) Logo

Guardian Capital Advisors Lp increased Suncor Energy Inc New (SU) stake by 3.41% reported in 2017Q4 SEC filing. Guardian Capital Advisors Lp acquired 8,188 shares as Suncor Energy Inc New (SU)’s stock declined 2.02%. The Guardian Capital Advisors Lp holds 248,103 shares with $11.47M value, up from 239,915 last quarter. Suncor Energy Inc New now has $60.29 billion valuation. The stock decreased 0.31% or $0.12 during the last trading session, reaching $38.25. About 2.46M shares traded. Suncor Energy Inc. (NYSE:SU) has risen 13.82% since April 21, 2017 and is uptrending. It has outperformed by 2.27% the S&P500.

Among 3 analysts covering Kamada Ltd (NASDAQ:KMDA), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Kamada Ltd had 6 analyst reports since November 13, 2015 according to SRatingsIntel. The stock has “Buy” rating by Jefferies on Tuesday, October 10. The rating was maintained by Jefferies on Thursday, August 10 with “Buy”. The firm has “Buy” rating given on Thursday, June 22 by Jefferies. The firm earned “Buy” rating on Thursday, February 8 by H.C. Wainwright. See Kamada Ltd. (NASDAQ:KMDA) latest ratings:

08/02/2018 Broker: H.C. Wainwright Rating: Buy New Target: $11.0 Maintain
02/02/2018 Broker: Chardan Capital Markets Rating: Buy New Target: $7 Initiates Coverage On

The stock decreased 1.09% or $0.05 during the last trading session, reaching $4.55. About 17,634 shares traded. Kamada Ltd. (NASDAQ:KMDA) has declined 31.39% since April 21, 2017 and is downtrending. It has underperformed by 42.94% the S&P500.

Kamada Ltd. develops, produces, and markets specialty plasma-derived protein therapeutics. The company has market cap of $183.86 million. It operates through two divisions, Proprietary Products and Distribution. It has a 25.28 P/E ratio. The companyÂ’s respiratory products include Glassia for use in augmentation and maintenance therapy in adults with emphysema due to congenital AAT deficiency ; Bramitob to manage chronic pulmonary infection; and FOSTER for the treatment of asthma.

Guardian Capital Advisors Lp decreased Anthem Inc (NYSE:ANTM) stake by 1,270 shares to 19,685 valued at $4.92M in 2017Q4. It also reduced Microsoft Corp (NASDAQ:MSFT) stake by 5,095 shares and now owns 145,858 shares. Johnson Ctls Intl Plc was reduced too.

Kamada Ltd. (NASDAQ:KMDA) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts